Key statistics
On Friday, Ligand Pharmaceuticals Inc (LGNYZ:PKC) closed at 0.008, -27.27% below its 52-week high of 0.011, set on Jul 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.008 |
---|---|
High | 0.008 |
Low | 0.008 |
Bid | -- |
Offer | -- |
Previous close | 0.008 |
Average volume | 269.65k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Sep 20 2024 19:31 BST.
More ▼
Press releases
- Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
- Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference
- Ligand Reports Second Quarter 2024 Financial Results
- Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024
- Ligand to Acquire APEIRON Biologics AG for $100 Million
- Ligand Partner Verona Pharma Announces FDA Approval of Ohtuvayre™ (ensifentrine), First Inhaled Novel Mechanism for Maintenance Treatment of COPD in More Than 20 Years
More ▼